Published in Immunotherapy Weekly, October 24th, 2007
"We examined whether we could achieve better differentiation between these two disease entities using recombinant antigens to RNP70 and SmD and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.